LYMPHOMA RECEIVING CAR-T THERAPY
Clinical trials for LYMPHOMA RECEIVING CAR-T THERAPY explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA RECEIVING CAR-T THERAPY trials appear
Sign up with your email to follow new studies for LYMPHOMA RECEIVING CAR-T THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test 'Off-the-Shelf' cancer treatment that could save time and lives
Disease control Recruiting nowThis study is testing a new type of cell therapy called Allo-QuadCAR01-T for adults with B-cell blood cancers that have come back or not responded to other treatments. Unlike current personalized cell therapies, this 'off-the-shelf' version uses donor cells that are ready immedia…
Matched conditions: LYMPHOMA RECEIVING CAR-T THERAPY
Phase: PHASE1, PHASE2 • Sponsor: AvenCell Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists track how CAR-T therapy affects the brain
Knowledge-focused Recruiting nowThis study aims to understand how CAR-T cell therapy for lymphoma might affect patients' thinking skills, memory, and brain structure. Researchers will follow 120 adult patients, using memory tests and brain scans before and after treatment. The goal is to gather information abou…
Matched conditions: LYMPHOMA RECEIVING CAR-T THERAPY
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC